Is a complete ELOX research report available?

No complete published report is available for Eloxx Pharmaceuticals, Inc. (ELOX) on this page. Market-directory data, when present, is not a substitute for a reviewed stock analysis.

Eloxx Pharmaceuticals, Inc. (ELOX)

NASDAQ: ELOX · USD

$13.3

+1.06 (+8.7%)· Recorded snapshot

Coverage state: Market snapshot only — no published research

Market snapshot recorded 2026-07-31 02:00 UTC. No published research is attached to this ticker. Prices and fundamentals on this server-rendered page are dated snapshots, not a real-time trading feed.

On-demand research

Generate the first ELOX analysis

Start the full research workflow when this ticker is ready in our data system.

Market cap	53.7M
Net income (ttm)	-8M
EPS (ttm)	-$3.77
Shares out	4M
Volume	18,875
Beta	-164975.97
Price target	$41.5	+212.0%

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Net income (ttm): -8M
EPS (ttm): -$3.77
Market cap: 53.7M

Ticker	Name	Market cap	P/E	P/S	ROIC	5Y rev CAGR	1Y total return	Rating
ALNY	Alnylam Pharmaceuticals, Inc.	27.4B	36.9x	5.7x	96.6%	+47.5%	-37.8%	Strong Buy
ARGX	argenx SE	53.8B	31.3x	10.1x	50.6%	+58.8%	+45.7%	Strong Buy
EXAS	Exact Sciences Corp	—	—	—	—	—	—	Hold

All ELOX indicators

Market & fundamental data

Available fields

160

Groups with data

Currency

USD

Showing 160 of 160 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Cik	0001035354
Company name	Eloxx Pharmaceuticals, Inc.
Country	United States
Country code	US
Cusip	29014R301
Employees	10
Employees Change	-8%
Employees Change Percent	-44.44
Enterprise value	$59.1M
Exchange	NASDAQ
Financial currency	USD
First seen	2026-07-12
Industry	Biotechnology
Isin	US29014R3012
Last refreshed	2026-07-31
Market cap	$53.7M
Market cap category	Micro-Cap
Price	$13.3
Price currency	USD
Sector	Healthcare
Sector PE	45.21
Sector PE Fwd	23.64
Symbol	ELOX
Website	https://www.eloxxpharma.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-14.98%
FCF yield	-24.19%

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
Net Income	$-8M
Net Income Growth Years	0%
Profit Per Employee	$-804,000
Roa5y	-79.38
ROCE	118.8

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	1,217,908.79%
Cagr3y	-42.28%
Cagr5y	-53.37%
EPS Growth Quarters	1
EPS Growth Years	4
Revenue Growth Years	0x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Assets	$8.5M
Cash	$6.4M
Current Assets	$8.5M
Current Liabilities	$16.1M
Debt	$11.8M
Equity	$-7.6M
Interest Coverage	-15.14
Liabilities	$16.1M
Long Term Assets	$0
Long Term Liabilities	$0
Net Cash	$-5.5M
Net Cash By Market Cap	$-10.17
Tangible Book Value	$-7.6M
Tangible Book Value Per Share	$-16.44
WACC	-743,595.2

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	0.53
Net Working Capital	$-2.1M
Quick ratio	0.4
Working Capital	$-7.6M

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-908.65%
Dividend Yield	0%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	1,210,091.08%
200-day SMA	2.76
3Y total return	-80.78%
50-day SMA	10.01
50-day SMA vs 200-day SMA	50over200
5Y total return	-97.79%
All Time High	10,824
All Time High Change	-99.88%
All Time High Date	2018-06-15
All Time Low	0
All Time Low Date	2024-08-14
ATR	1.91
Beta	-164,976
Beta1y	-2,224.4
Beta2y	-2,049.4
Ch YTD	1,208,990.9
High	13.75
High52	17.5
High52 Date	2026-06-15
Low	12.41
Low52	0
Low52 Date	2025-12-02
Ma50ch	32.91%
Price vs 200-day SMA	382.23%
RSI	59.62
RSI Monthly	42.38
RSI Weekly	78.81
Sharpe ratio	1.45x
Sortino ratio	2,313.8
Total Return	-908.65%
Tr YTD	1,210,091.1
Tr1m	11.48%
Tr1w	10.83%
Tr3m	907.58%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Analyst Count	2
Analyst Count Top	2
Analyst Price Target Top	$41.5
Analyst Ratings	Strong Buy
Analyst Ratings Top	Buy
Earnings EPS Estimate	$-1.97
Operating Income	$-9M
Price target	$41.5
Price Target Change	$212
Price Target Change Top	$212

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	1,820,811%
Float Percent	45.11%
Net Borrowing	2,175,000
Shares Insiders	3.88%
Shares Institutions	13.35%
Shares Out	4,036,314
Shares Qo Q	1,166.84%
Shares Yo Y	908.65%
Short Float	1.18%
Short Ratio	0.24
Short Shares	0.53

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	$-13.2M
Adjusted OCF	-13,245,000
Average Volume	69,802.2x
Bv Per Share	-16.44
Ch1m	11.48
Ch1w	10.83
Ch1y	1,208,990.9
Ch3m	907.6
Ch3y	-80.78
Ch5y	-97.79
Ch6m	1,208,990.9
Change	8.66%
Change From Open	7.17
Close	12.24
Days Gap	1.39
Dollar Volume	251,037.5
Earnings Date	2023-11-13
Earnings Time	amc
EBIT	$-9M
EPS	$-3.77
F Score	1
FCF	$-13M
FCF EV Yield	-21.95x
FCF Per Share	$-3.22
Financing CF	18,897,000
Fiscal Year End	December
Founded	1,999
Investing CF	1,000
Is Primary Listing	1
Is Spac	No
Last Earnings Date	2023-11-13
Last Report Date	2026-03-31
Last Split Date	2026-06-01
Last Split Type	Reverse
Ma150	3.68
Ma150ch	261.71%
Ma20	12.04
Ma20ch	10.47%
Net CF	5,914,000
Open	12.41
Position In Range	66.42
Price Date	2026-07-30
Relative Volume	0.27x
Share Based Comp	261,000
Tr6m	1,210,091.08%
Us State	Massachusetts
Volume	18,875

Eloxx Pharmaceuticals, Inc. (ELOX)

Coverage state: Market snapshot only — no published research

Generate the first ELOX analysis

Price

Financial snapshot

Fair-value bridge

Analyst consensus

Latest news · ELOX

Valuation

Balance sheet

Trading

Next earnings

Sector percentile context

All ELOX indicators

Profile and market data

Valuation

Profitability

Growth

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Analyst estimates

Ownership and float

Other indicators

Deeper analysis on ELOX

Frequently asked questions